Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth
Pregnancy-related complications such as pre-eclampsia and preterm birth now represent a notable burden of adverse health. Pre-eclampsia is a hypertensive disorder unique to pregnancy. It is an important cause of maternal death worldwide and a leading cause of fetal growth restriction and iatrogenic...
Main Authors: | Kai P. Law, Ting-Li Han, Chao Tong, Philip N. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/5/10952 |
Similar Items
-
The clinical utility of serum uric acid measurement in pre-eclampsia
by: B u s h r a M . M a j e e d
Published: (2007-07-01) -
Hemoglobin levels during the first trimester of pregnancy are associated with the risk of gestational diabetes mellitus, pre-eclampsia and preterm birth in Chinese women: a retrospective study
by: Chen Wang, et al.
Published: (2018-06-01) -
PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia
by: Marcos Augusto Bastos Dias, et al.
Published: (2019-10-01) -
Quantitative proteomic profiling of Cervicovaginal fluid from pregnant women with term and preterm birth
by: Young Eun Kim, et al.
Published: (2021-02-01) -
Urine Proteomics in the Era of Mass Spectrometry
by: Ashley Beasley-Green
Published: (2016-11-01)